カテゴリ： MarketLine, オーストラリア, 企業調査

Challenger Ltd.：企業の戦略・SWOT・財務情報

◆英語タイトル：Challenger Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C13607
◆発行会社（調査会社）：MarketLine
◆発行日：2019年2月
◆ページ数：37
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：オーストラリア
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Challenger Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Challenger Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Challenger Ltd (Challenger) is an investment management company. The company provides investment management services, and annuities and retirement income plans. Its portfolio of products and services include fixed term annuities, lifetime annuities, fixed rate managed funds and fund management services. It also offers annuity superannuation products, life insurance solutions, and retirement plans. Challenger invests in property, infrastructure and fixed assets. The company serves residents of Australia, institutions and retail businesses. It operates and distributes products and services through a network of branch offices in Melbourne, Perth, Brisbane, Adelaide, Sydney and London. Challenger is headquartered in Sydney, Australia.

The company reported life insurance contract premiums and related revenue of AUD1,452.7 million in FY2018, a decrease of 10.5% over that in FY2017.

Scope

- Detailed information on Challenger Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Challenger Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Challenger Ltd. including a breakdown and examination of key business segments
- Intelligence on Challenger Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Challenger Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Challenger Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Challenger Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Challenger Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Challenger Ltd.: Company Overview
Challenger Ltd.: Overview and Key Facts
Challenger Ltd.: Overview
Challenger Ltd.: Key Facts
Challenger Ltd.: Key Employees
Challenger Ltd.: Key Employee Biographies
Challenger Ltd.: Major Products and Services
Challenger Ltd.: Company History
Challenger Ltd.: Management Statement
Challenger Ltd.: Key Competitors
Challenger Ltd.: Company Analysis
Challenger Ltd.: Business Description
Challenger Ltd.: SWOT Analysis
Challenger Ltd.: SWOT Overview
Challenger Ltd.: Strengths
Challenger Ltd.: Weaknesses
Challenger Ltd.: Opportunities
Challenger Ltd.: Threats
Challenger Ltd.: Corporate Financial Deals Activity
Challenger Ltd.: Financial Deals Overview
Challenger Ltd.: Top Deals 2015 – 2019YTD*
Challenger Ltd.: Advisors
Challenger Ltd.: Top Legal Advisors
Challenger Ltd.: Capital Raising
Challenger Ltd.: Recent Developments
Challenger Ltd.: News and Events Summary
Challenger Ltd.: Business Expansion
Challenger Ltd.: Contracts
Challenger Ltd.: Corporate Governance
Challenger Ltd.: Financial Performance
Challenger Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Challenger Ltd.: Key Facts
Table 2: Challenger Ltd.: Key Employees
Table 3: Challenger Ltd.: Company History
Table 4: Challenger Ltd.: Key Competitors
Table 5: Challenger Ltd.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 6: Challenger Ltd.: Top Deals 2015 - 2019YTD*
Table 7: Challenger Ltd.: Legal Advisor Ranking by Value (US$m)
Table 8: Challenger Ltd.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 9: Challenger Ltd.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 10: Challenger Ltd.: News and Events Summary
Table 11: Challenger Ltd.: Business Expansion
Table 12: Challenger Ltd.: Contracts
Table 13: Challenger Ltd.: Corporate Governance
Table 14: Challenger Ltd.: Financial Performance
Table 15: Challenger Ltd.: Strategy and Operations

List of Figures
Figure 1: Challenger Ltd.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 2: Challenger Ltd.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 3: Challenger Ltd.: Capital Raising by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Challenger Ltd.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Clinigen Group Plc (CLIN)-製薬・医療分野：企業M&A・提携分析
    Summary Clinigen Group plc (Clinigen Group) is a pharmaceutical and services company that provides access to medicines, clinical trials, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines including cardioxane, ethyol, foscavir, savene and vibativ. It o …
  • Empresas Publicas De Medellin ESP：電力：M&Aディール及び事業提携情報
    Summary Empresas Publicas De Medellin ESP (EPM) is a decentralized body, operational under the ownership of Medellin municipality. It generates, transmits, and distributes electricity as well as undertakes gas distribution, wastewater and garbage treatment, and telecommunications services across the …
  • High Peak Royalties Ltd (HPR)：企業の財務・戦略的SWOT分析
    High Peak Royalties Ltd (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Satrec Initiative Co., Ltd.：企業の戦略・SWOT・財務情報
    Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • University of Oxford：企業のM&A・事業提携・投資動向
    University of Oxford - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Oxford Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Cimarex Energy Co (XEC)：企業の財務・戦略的SWOT分析
    Cimarex Energy Co (XEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Endesa SA (ELE)：電力：M&Aディール及び事業提携情報
    Summary Endesa SA (Endesa), a subsidiary of Enel SpA, is an electric utility. It generates, distributes, and sells electricity. The company produces electricity in hydro, thermal, nuclear, combined cycle, and renewable and cogeneration plants. Endesa also supplies electricity and gas, and provides o …
  • Unum Therapeutics Inc (UMRX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Unum Therapeutics Inc (Unum Therapeutics) is a clinical-stage bio-pharmaceutical company focused on the development and commercialization of novel antibody-coupled cellular immunotherapies to fight cancers. Its pipeline product portfolio include ACTR087 + rituximab, a CD20 targeting chimeric …
  • CSL Ltd (CSL)：医療機器：M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • SMRT Corporation Ltd.：戦略・SWOT・企業財務分析
    SMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary SMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Suburban Propane Partners LP (SPH)：企業の財務・戦略的SWOT分析
    Summary Suburban Propane Partners LP (Suburban Propane) distributes and markets energy-related products. The company supplies propane, fuel oil and refined fuels, and markets natural gas and electricity in deregulated markets. Suburban Propane also provides installation and service of various types …
  • Logitech International S.A.：企業の戦略・SWOT・財務分析
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sysmex Corp (6869)：医療機器：M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Celsion Corp (CLSN)-医療機器分野：企業M&A・提携分析
    Summary Celsion Corp (Celsion) is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNA-mediated immunotherapy. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (L …
  • IDT Biologika GmbH：製薬・医療：M&Aディール及び事業提携情報
    Summary IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a vaccines and pharmaceuticals manufacturer. The company offers contract manufacturing services. It provides integrated development and manufacturing services in four major areas of animal health, vaccines, ph …
  • Zuivelcooperatie FrieslandCampina UA：企業の戦略的SWOT分析
    Zuivelcooperatie FrieslandCampina UA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Censo Biotechnologies Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation, is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays …
  • Nippon Soda Co., Ltd.：企業の戦略・SWOT・財務分析
    Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Simons Group Ltd：企業の戦略・SWOT・財務情報
    Simons Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Simons Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MAN SE：企業の戦略・SWOT・財務情報
    MAN SE - Strategy, SWOT and Corporate Finance Report Summary MAN SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆